Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficiency) (Unaudited)

v3.8.0.1
Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficiency) (Unaudited) - 3 months ended Mar. 31, 2018 - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2017 345,000 66,785,428      
Balance at Dec. 31, 2017 $ 69 $ 13,357 $ 2,020,642 $ (2,593,337) $ (559,269)
Warrants exercised     24,525   24,525
Debentures converted to common stock (in shares)   244,618      
Debentures converted to common stock   $ 49 176   225
Common stock issued for liabilities (in shares)   552,924      
Common stock issued for liabilities   $ 111 71,768   71,879
Net loss       (338,554) (338,554)
Balance (in shares) at Mar. 31, 2018 345,000 67,582,970      
Balance at Mar. 31, 2018 $ 69 $ 13,517 $ 2,117,111 $ (2,931,891) $ (801,194)